Enorama Pharma Investor Relations Material
Latest events
Q1 2025
21 May, 2025
Q4 2024
19 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Enorama Pharma
Access all reports
Enorama Pharma AB is a pharmaceutical company headquartered in Malmö, Sweden. The company focuses on developing and manufacturing medicated chewing gum and other nicotine products. Its main products include nicotine chewing gums and pouches aimed at aiding smoking cessation. Enorama Pharma also explores other applications such as medical cannabis chewing gums and oromucosal drug delivery systems. The company operates with a commitment to providing innovative pharmaceutical solutions. Enorama Pharma is listed on the Stockholm Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ERMA
Country
🇸🇪 Sweden